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Abstract: By mediating voluntary muscle movement, vertebrate neuromuscular junctions (NMJ)
play an extraordinarily important role in physiology. While the significance of the nerve-muscle
connectivity was already conceived almost 2000 years back, the precise cell and molecular biology of
the NMJ have been revealed in a series of fascinating research activities that started around 180 years
ago and that continues. In all this time, NMJ research has led to fundamentally new concepts of cell
biology, and has triggered groundbreaking advancements in technologies. This review tries to sketch
major lines of thought and concepts on NMJ in their historical perspective, in particular with respect
to anatomy, function, and molecular components. Furthermore, along these lines, it emphasizes the
mutual benefit between science and technology, where one drives the other. Finally, we speculate on
potential major future directions for studies on NMJ in these fields.
Keywords: history; motor endplate; neuromuscular junction; skeletal muscle; sympathetic
innervation; synapse
“These were the happy days, for which the current generation might envy us, when the first good,
handy, and affordable microscopes came from the workshops of Plössl in Vienna and Pistor and
Schick in Berlin, the happy days, when it was still possible to make fundamental discoveries by
simply scraping with the blade of a scalpel or the fingernails on an animal’s membrane.” Jacob Henle,
Orbituary for Theodor Schwann (1882)
1. Introduction
Fast, nervous-system-controlled voluntary body movement by muscle activity is a principal
characteristic of most animals, from simple Cnidaria to the intricate chordates, and man. The complexity
of the neuro-muscular system shows a clear dependency on the life style of an animal. Indeed, while
free-living and actively moving animals such as fish, insects, or mammals, have well developed nerve
and muscle systems, sessile animal life forms such as sponges, bryozoans, or adult sea squirts are either
completely devoid or display very simple versions of those. Although the principal concept of brain and
nerves controlling voluntary movement was already described in the second century AD by Galen [1,2],
first accounts on the cellular contact sites between motor neurons and muscle fibers, which we now call
neuromuscular junctions (NMJs) or motor endplates, come from the nineteenth century. Indeed, this
Cells 2019, 8, 387; doi:10.3390/cells8050387 www.mdpi.com/journal/cells
Cells 2019, 8, 387 2 of 20
coincided with the invention of novel microscopic technologies including the achromatic optics, and the
origins of the concept of cell biology developed and formulated by Matthias Jacob Schleiden for plants
and by Theodor Schwann for animals. In this review, by sketching the history of NMJ research from its
start in the 1840ies we have aimed to demonstrate the power of this important synapse for the progress
of malleable scientific concepts as well as some major technological advancements that were necessary
to conclude long debates on uncertain scientific aspects. In doing so, we have concentrated on aspects
of early anatomy, function, and principal molecular components of vertebrate NMJ. In particular, this
review delves into the literature on sympathetic innervation of NMJ, since this was intensely studied and
debated for the first third of the twentieth century and then almost completely abandoned until recently.
Other topics such as NMJ development, glial function, and neuromuscular transmission disorders have
been lately covered in excellent review articles, and have therefore been handled in a cursory manner in
this review with due citation. We apologize for not mentioning many authors or works that could have
been also included but were not due to space limitations.
2. Phase I: Discovery of the NMJ
In 1839, Theodor Schwann founded the “cell theory” which states “[ . . . ] that a common
developmental principle underlies all individual elementary particles of all organisms” and that
organismal growth is solely based on the generation of new cells as well as the extension of existing
cells [3]. Although the term “cell” had been in use by other researchers before, it had been ill defined.
Some saw in it the cell nucleus, others the cell body or yet further structures. In this same period, in
which the concept of cell biology was just beginning to evolve, Louis Michel François Doyère and
Jean Louis Armand de Quatrefages de Bréau depicted perhaps the first NMJs in the literature [4,5].
They show endplates of the tardigrade Milnesium tardigradum and the snail Eolidina paradoxum and are
drawn in continuity with the muscle fiber (see Figure 1A,B).
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Figure 1. Historical anatomic drawings of NMJs. A-B: Presumably the first drawings of NMJs from 
the early 1840ies. Figures show reprints of NMJs from the tardigrade, Milnesium tardigradum (A) and 
the snail, Eolidina paradoxus (B). Reproduced from [4,5], original sources: 
www.biodiversitylibrary.org/item/47974#page/7/mode/1up and 
Figure 1. Historical anatomic drawings of NMJs. A-B: Presumably the first drawings of NMJs from the
early 1840ies. Figures show reprints of NMJs from the tardigrade, Milnesium tardigradum (A) and the snail,
Eolidina paradoxus (B). Reproduced from [4,5], original sources: www.biodiversitylibrary.org/item/47974#
page/7/mode/1up and www.biodiversitylibrary.org/item/47973#page/9/mode/1up. (C). Selection from the
more than 300 NMJs depicted by Willy Kühne in 1886 shows the variety of vertebrate NMJ morphologies.
Reproduced from [6], original source: https://catalog.lib.uchicago.edu/vufind/Record/11720295.
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Explicitly, de Quatrefages speaks of a “reciprocal penetration” and a “veritable fusion of nervous
and muscle tissues” [5]. Many researchers after Doyère and de Quatrefages, including Willy Kühne, L.
Bremer, Jan Boeke, and Louis-Antoine Ranvier, also talked of “hypolemmal” nerve endings to express
their opinion that the nerve fiber terminated below the sarcolemma. This view was in contrast to the
“cell theory” by Schwann and the “neurone doctrine” by Ramón y Cajal, but in line with the “reticular
theory” heralded by Joseph von Gerlach and Camillo Golgi [7], which proposed the nervous system as
a network of neurons one passing into the other in an anastomosing manner. Although preparation
techniques and microscopic anatomy improved a lot in these years, the existence of two contradicting
theories casted shadows on the Nobel prize ceremony in 1906. There Cajal and Golgi jointly received
the award for Medicine and Golgi was utterly arguing in his speech against the “neurone doctrine”.
Notably, the precise arrangement of nerve and muscle cell at the NMJ remained open for many years to
come. Those favoring the “epilemmal” conformation, i.e., where nerve and muscle would be separated
from each other, were rather few, while many advocated for an “hypolemmal” situation whereby the
nerve would enter the sarcolemma. This point was important, because it strongly influenced the way
of how signal propagation from nerve to muscle was conceived (see chapter III). Ultimately, upon
development of electron microscopy, the argument was terminated for the NMJ in the 1950ies in favor
of the “neurone doctrine” with the first descriptions of synaptic clefts [8,9] and a three-dimensional
reconstruction of the NMJ ultrastructure [10] (see Figure 2 for an overview of phases).
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aspects of research on NMJ.
part fro this intense ebate, so e f rt er f a ental a ato ical iscoveries ere ade on
the otor end late in the period bet een 1840 and 1900. F r exa le, il y Krause, an i portant
exponent of the “epilemmal” conformation hypothesis, coined the term “motorische Endplatte” [11]
and found in cat muscle that each fiber had a maximal length of about four centimeters and one single
endplate located roughly in the middle of the fiber [11]. Although in general, the latter is a finding that
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seems to hold true even for large animals such as elephant and buffalo [12], it does not apply to all
muscle types. For example, Zenker and colleagues found in rat that sternomastoid muscle indeed
exhibited a single NMJ band in the middle of the muscle, whereas gracilis anterior and latissimus
dorsi muscles showed partially multiple innervation per fiber and myo-myonal junctions [13]. Charles
Marie Benjamin Rouget reported on the granulated fine structure of the synapse [14,15], anticipating
the presence of synaptic vesicles. At the NMJ, Ranvier distinguished “fundamental nuclei” of the
muscle fiber from “arborization nuclei” [16], the latter likely being nuclei of terminal Schwann cells.
Schwann cells and their myelin sheaths were described by Schwann and Ranvier [3,16]. Kühne, using
gold impregnation methods based on those developed by Golgi [17], beautifully depicted hundreds of
NMJs from many different vertebrates ranging from amphibians over reptiles and birds to mammals at
high resolution [6] (see Figure 1C for some examples). He described the end-ramifications of NMJs
as “antlers” and categorized them according to their ramification modes. Furthermore, he observed
the “Borstensaum”, bristle-like borders on the endplate ramifications of vertebrates that were likely
representing postsynaptic junctional folds [6]. Finally, Bremer gave a first account on a dual innervation
of NMJs by myelinated and thin axons [18]. As outlined in the following chapter, this instigated
another long dispute, which is actually still open today, on the nature of the motor endplate.
3. Phase II: Small vs. Myelinated Fibers, Plastic Tone vs. Voluntary Movement
In 1894, Sir Charles Scott Sherrington showed that nerves supplying skeletal muscles contain
axons of different diameters, myelinated and non-myelinated, dorsal afferent and ventral efferent,
sensory, somatic, and sympathetic [19]. He also found that the largest myelinated axons were of motor
type, while another group of myelinated axons were connected to muscle spindles [19]. The latter
had been described and termed as such some 20 years earlier by Kühne [20]. Thus, by the end of
the nineteenth century, the major neuronal components and, particularly, the presence of somatic
and sympathetic innervation of skeletal muscle were established. Also, based on observations from
Robert Remak in 1837 [21], it was known by Sherrington that motor axons were large-sized and
myelinated; conversely, sympathetic axons appeared as pale and non-myelinated [19]. However, while
motor neurons were easily found to induce voluntary contraction of skeletal muscle, the function of
sympathetic neurons in muscle tissue remained unclear. Apart from the universally accepted function
of sympathetic innervation on vasomotor activity [22–25], early findings of Bremer indicated also an
intimate interaction of large myelinated and small non-myelinated nerve fibers in the region of motor
endplates [18]. In 1902, Aldo Perroncito, a coworker of Golgi, suggested that the small fibers at the
NMJs be of sympathetic origin [26]. This was further supported by a series of morphological and some
experimental data, which were chiefly contributed by Boeke [27–29], Erik Agduhr [30], and Marion
Hines [31]. Boeke termed such presumably sympathetic inputs to endplates “accessory fibers” [29]
(“af” in Figure 3A).
In the first three decades of the 20th century, the discussion about the existence of a dual
innervation of skeletal muscle fibers and of NMJs by somatic myelinated motor neurons and sympathetic
non-myelinated neurons, was very intense and controversial. While the founder of the term “autonomic
nervous system” and one of the most influential researchers in this field, John Newport Langley,
admitted that the morphological evidence was indeed in favor of the existence of a dual innervation,
he was rather doubtful with respect to the experimental findings [23] and the puzzling unanswered
question about the potential role of such a dual innervation. Increasingly, this casted shadows on the
dual innervation hypothesis. Thus, in the 1920–30ies three major schools of thought evolved on this
topic: First, there was the group of those researchers who fully supported the concept of dual innervation
of NMJs. Second, some others neglected the existence of dual innervation of the same muscle fiber and
motor endplate, but suggested that distinct groups of muscle fibers would be innervated by either
motor or sympathetic neurons and form either plate-like or grape-like endings [32,33]. These different
fiber groups were thought to be responsible for distinct types of contractility, i.e., voluntary and
reflex activities for the muscle fibers with plate-like endings and plastic tone activities for those with
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grape-like endings. A third school of authors, heralded by Joseph B. Hinsey [34], doubted the existence
of sympathetic endings on muscle fibers altogether and suggested that the structures observed by
Boeke, Agduhr, and others were artefacts [35–37].
A principal issue with the studies of Boeke and others regarding the sympathetic co-innervation
of NMJs was the lack of molecular markers. At that time, anatomical studies were carried out
using impregnation with silver, gold, or other dyes. Although these were apparently enriched in
nervous tissue, they would not unequivocally discriminate between different types of neurons and,
partially, were considered to label also connective tissue [34]. Thus, the only way to further distinguish
between different neuron identities was by analysis of axon diameter and myelination, which again
did not indicate cell-type identity unless combined with functional studies such as specific denervation
experiments. However, also here, findings were equivocal with respect to a sympathetic co-innervation
of NMJs [37,38] and, consequently, the interest of the research community in the field of sympathetic
innervation of skeletal muscle and the NMJ rapidly declined in the mid 1930ies. Since then, for the
next eight decades, the school favoring the absence of a direct function of sympathetic innervation in
the skeletal muscle tissue has dominated the field. In the context of this mindset, the interpretation
by Chan-Palay et al. in 1982 of their immunohistochemical data is maybe not too surprising. Indeed,
they investigated the presence of different synthesizing enzymes at the NMJ and found a consistent
enrichment of the sympathetic neuron marker, tyrosine hydroxylase (TH), at the NMJs of different
species, including human. However, instead of considering the possibility of an accessory innervation
of NMJs by sympathetic neurons, the presence of TH at NMJs was considered to be an additional
biochemical capacity of lower motor neurons [39,40].
Between the 1930ies and the present time, one of the very few extensive papers on sympathetic
innervation of skeletal muscle showed the presence of direct sympathetic innervation on skeletal muscle
fibers and muscle spindles [41] on the basis of data using the Falck-Hillarp fluorescence method to reveal
biogenic monoamines [42–44] in combination with ultrastructural features of sympathetic neurons.
While that work did not address sympathetic innervation at NMJs, two studies in 2013 and 2016
reported TH immune-positive axons approaching the NMJs of adult mouse hindleg muscles [45,46].
TH-positive axons were mostly ending in plaque-like structures opposite to the postsynaptic, pretzel-like
arborizations of nicotinic acetylcholine receptors (nAChRs). Notably, though, instead of perfectly
matching the distribution of nAChR staining as it would be the case for motor nerve terminals, the
TH-positive plaques were often complementary to the NMJ staining signals [45,46]. The distribution
of sympathetic neurons was confirmed by genetic reporter mice and additional immunostaining of
another sympathetic marker protein, neuropeptide Y [46]. Functional coupling between sympathetic
innervation and NMJs was shown using a combination of direct electrical stimulation of lumbar
sympathetic ganglia and simultaneous measurement of NMJ postsynaptic activities. This revealed
immediate, sympathetic-stimulus dependent postsynaptic activation of β-adrenergic receptors and
cAMP signaling as well as import of the transcriptional co-activator PGC-1α [46]. Fittingly, local
chemical ablation of sympathetic innervation for two weeks by intramuscular injection of the
sympathicotoxic drug, 6-hydroxy dopamine, had gross effects on NMJ morphology and compound
muscle action potentials, and induced massive muscle atrophy [46]. These alterations could be largely
rescued by simultaneous treatment with the sympathicomimetic drug, clenbuterol [46], suggesting
the presence of sympathetic innervation of NMJs in mouse hindlimb muscles with functions in NMJ
maintenance, electrophysiological properties, and muscle trophic status. Recently, this hypothesis
was confirmed and expanded to functional roles of sympathetic innervation on motor neurons and to
better understand the molecular postsynaptic signaling activated upon norepinephrine release [47]. In
particular, surgical sympathectomy was found to alter acute neuromuscular functionalities, including
nerve-evoked contractile force, amplitudes of miniature endplate potentials (MEPP) and endplate
potentials (EPP), as well as quantal content [47]. Accordingly, application of sympathicomimetics,
salbutamol or clenbuterol, increased these parameters, and they were found to depend on enhanced
Ca2+ influx through transient receptor potential channels V1 and P/Q-type Ca2+ channels [48]. Fitting
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to the observed effects on neuromuscular transmission of sympathectomy, the axons of motor neurons
of treated animals presented with a disorganized cytoskeleton, myelination defects, and smaller
axon diameters, as well as a fiber-type specific reduction of muscle cross-sectional area [47]. With
respect to molecular pathways involved at the postsynaptic side, mRNA-profiling revealed that genes
associated with muscle denervation such as the γ-subunit of nAChR, and the myogenic transcription
factors, myogenin and MyoD, were significantly up-regulated upon acute surgical sympathectomy,
whereas genes involved in vesicle docking and fusion, circadian rhythm, Notch signaling, and
energy homeostasis were diminished [47]. Finally, surgical sympathectomy was found to induce
a Hdac4-myogenin-MuRF1-miRNA-206 expression axis. Based on previously described roles of
MuRF1 on muscle atrophy [49–51] as well as on nAChR recycling and degradation [52,53], this was
suggested to explain the observed massive muscle atrophy and loss of plasmamembrane-bound
nAChR [47]. Concerning the postsynaptic signaling cascade potentially triggered by sympathetic
activation of β2-adrenergic receptors, the involvement of a cAMP-protein kinase A axis as well
as of Gαi2 were proposed [47]. Another two recent studies investigated postnatal development of
sympathetic innervation of NMJs and its potential role on NMJ maintenance upon aging. One of
these showed the presence of TH-positive neurons already at birth for different muscles throughout
the body, including diaphragm and hindleg muscles [54]. While TH and neuropeptide Y signals
at NMJs strongly increased during the first postnatal weeks in extensor digitorum longus muscles,
β2-adrenergic receptor density at endplates was high at birth and then slightly decreased in mature
muscles [54]. The second study reported that genetically engineered brain-specific Sirt1-overexpressing
(BRASTO) mice leading to enhanced sympathetic outflow showed increased enrichment of TH and
β2-adrenergic receptors at NMJs as well as reduced fragmentation of motor endplates in sternomastoid
muscles of aged BRASTO mice when compared to wildtype animals [55]. Conversely, down-regulation
aggravated morphological defects, particularly, with respect to terminal Schwann cells [55]. A brief
overview about the current findings with respect to the function of the sympathetic innervation at
NMJs can be found in Figure 3B.
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Reproduced from [54]. Image size, 180 µm. (C) Scheme depicting the putative complementary 
localization of sympathetic (blue) and motor neuron endings (green) at NMJ. While the latter is 
perfectly fitting the shape of the postsynaptic nAChR distribution (red), the sympathetic neuron 
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Figure 3. ast a c rre t of sympathetic i nervation of NMJ. (A) One of the first observations
of sympathetic co-innervation. Reproduction from [29], original source: www.biodiversitylibrary.
org/item/43338#page/7/mode/1up. Abbreviations: af, accessory fiber; m, motor fiber; so, sole plate.
(B) Fluorescence micrograph showing sympathetic innervation (green, TH immunostaining) of NMJ
(red, alpha-bungarotoxin staining) in mouse tibialis anterior muscle. Reproduced from [54]. Image
size, 180 µm. (C) Scheme depicting the putative complementary localization of sympathetic (blue) and
motor neuron endings (green) at NMJ. While the latter is perfectly fitting the shape of the postsynaptic
nAChR distribution (red), the sympathetic neuron signals are rather found in between. The differential
thicknesses of blue and green axons indicate the absence and presence of a myelin sheath, respectively.
In addition, the diameter of sympathetic axons is normally also smaller than that of motor axons. The
writings indicate major functional roles of sympathetic innervation at NMJ as presently known.
In summary, a series of recent anatomical, morphological, and experimental studies has started
to re-establish the validity of the hypothesis of sympathetic co-innervation of NMJs. Future work is
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needed to further consolidate these findings and to deepen the insights into the functional relevance of
dual innervation in health, disease, and aging. It will be important to better characterize acute and
long-term effects of sympathetic innervation, to determine the target cells, and mechanisms of action.
4. Phase III: ACh and NE—Neurotransmitters at the NMJ
The second half of the nineteenth century had revealed several principal anatomic features of
the NMJ, but the mode of interaction between nerve and muscle had remained elusive. In particular,
it was still unclear, if motor neurons would terminate in a “hypolemmal” or “epilemmal” manner.
In the hypolemmal configuration, even a direct electrical conduction from nerve was envisioned.
However, studies using the South American arrow poison curare, which gained strong attention
through the meticulous work and description of Claude Bernard [56], were rather advocating for a
chemical transmission. Indeed, Edmé Félix Alfred Vulpian showed in the 1860ies that upon application
of curare, (i) nerve excitation did not pass on to the muscle, (ii) curarized muscle remained directly
excitable, and (iii) curarized nerve could transmit its excitation to a non-curarized muscle [57,58]. In
1877, these and other observations as well as further theoretical considerations led Emil Heinrich du
Bois-Reymond to critically examine the direct wave-like propagation of electrical stimuli from nerve to
muscle and to reason about the possibility of a chemical transmission [59]. At the end of the nineteenth
century, Sherrington elaborated on such ideas to formulate the concept and term of “synapse” [60,61].
Today, chemical transmission from motor nerve to muscle is a common place. Back then, though, the
identification of the signaling molecules involved was rather indirect and for the NMJ the issue was
finally solved only in the mid twentieth century.
The initial major steps forward came from work on the autonomic nervous system: Indeed, an
important notion here was that organs supplied by both sympathetic and parasympathetic branches of
the autonomic nervous system would typically respond to stimulation of one of the two in an opposite
manner. For example, heart beat would increase and decrease upon excitation of the sympathetic and
parasympathetic nerves, respectively. As for the sympathetic part, adrenal extracts from dogs were
found to be highly active on blood pressure, heart beat, respiration, and skeletal muscle contraction [62].
Around the year 1900, adrenalin or epinephrine, the active principle in these adrenal extracts, was
first isolated by John J. Abel in an impure form [63] and then, simultaneously, in pure version by
the Samurai and chemist Jokichi Takamine [64] and Thomas Bell Aldrich [65]. However, adrenalin’s
function did not perfectly recapitulate stimulation of sympathetic nerves, suggesting that it was similar
but not identical to the sympathetic neurotransmitter. In 1946, the real neurotransmitter was found by
Ulf Svante von Euler-Chelpin and characterized as “sympathin”, which we now call noradrenalin or
norepinephrine [66–68].
The active compound released by parasympathetic endings, acetylcholine (ACh), had been
synthesized from brain extracts by Adolf Baeyer already in 1867 [69,70], but its physiological role on
blood pressure was only discovered in 1906 by Reid Hunt and René de Taveau [71]. In 1921, Otto Loewi
stimulated either parasympathetic Vagus nerves or sympathetic nerves of frog hearts, took the media
from these stimulation periods, and called them “Vagusstoff” and “Acceleranzstoff”, respectively. Their
application to untreated hearts showed that they could mimic the stimulation of the corresponding
nerves [72] and thus convincingly demonstrated that there is chemical transmission from nerve to
heart. Although he also speculated that “Vagusstoff” could be ACh, this first remained unclear. With
respect to NMJ, Walter Rudolf Hess found in 1923 that application of ACh induced skeletal muscle
contraction, which was comparable in strength to that upon motor nerve stimulation [73]. Since this
occurred in an atropine-independent manner, it did not relate to parasympathetic action [73]. In 1934,
Sir Henry Hallett Dale and Wilhelm Siegmund Feldberg showed that ACh was released upon motor
nerve stimulation [74] and together with Marthe Louise Vogt, they demonstrated that ACh release
correlated with muscle contraction and that this function was inhibited by curare [75]. Simultaneous
to the progress with respect to ACh activity, its hydrolytic decay by acetylcholine esterase [76] at the
NMJ [77] was characterized. Thus, around one hundred years after the first observation of NMJs,
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the neurotransmitter chemistry was basically clarified. The molecular identification of the nAChR
and many of its major interacting proteins occurred decades later and strongly relied on electric
fish as “NMJ-enriched” model systems [78,79] (see chapter V). Conversely, the electrophysiological
processes underlying the neuromuscular transmission were largely worked out on frog and cat NMJs
and although they started even earlier they were concluded with a significant time shift compared
to the studies on transmitters. Presumably, this was mainly due to the persisting uncertainty about
the relationship between nerve, muscle, and the NMJ. Indeed, a leading electrophysiologist of these
times, John Carew Eccles, still wrote in 1939: “At the neuro-muscular junction the motor nerve fiber
penetrates the sarcolemma and forms an ending of variable complexity in a specialized region of the
muscle fiber called the motor endplate.” And: “The state of the true surface membranes of the muscle
fiber and motor endplate is unknown, being, on account of its ultramicroscopic character, more a
physiological than a histological problem” [80]. Consequently, the precise nature of the information
flow from nerve to muscle including presynaptic release of ACh over its binding to postsynaptic
receptors and their triggering of a muscle action potential, was not really understood until the 1970ies.
Most of the key steps occurring during neuromuscular transmission were unraveled by a small group
of people, with Bernard Katz being their main exponent.
5. Phase IV: MEPP, EPP, and AP—Conversion of Chemical Signals into Electrical Activity
Initial observations and interpretation of muscle action potentials were made in the 1840ies
by Carlo Matteucci [81] and du Bois-Reymond [82]. Conduction speed of action potentials along
peripheral nerves was first and correctly measured to be around 27 m/sec in cold frog sciatic nerve
by Hermann von Helmholtz in 1852 [83]. Nerve conduction principles were studied further in an
intensified manner in the early 20th century by Sherrington and Edgar Douglas Adrian. For example,
while Sherrington contributed many principal aspects about the systemic and integrative functions of
nerve conduction [61], Adrian described the summation of stimuli, the refractory period of stimulation,
and the all-or-none principle of neuron firing [84,85]. These increasingly fine electrophysiological
measurements requested increasingly sensitive technologies. As a side effect of the first World War
research, electrophysiological instruments were dramatically improved in sensitivity in the 1920ies by
virtue of novel vacuum [86] and three-stage amplifiers [87] as well as cathode ray oscillographs [88].
They allowed to record from single neurons and to differentiate between individual neural activities in
a nerve.
As described in the previous chapter III, around 1920 it was still completely open how the motor
nerve would propagate its stimulatory signal to the muscle, and the potential involvement of ACh was
just started to be discussed. This began to change in the late 1930ies by the first observations of EPPs in
frog [89] and cat [80] and the understanding of an involvement of ACh in this process [90–92]. In 1952,
the recording of MEPPs with an intracellular measurement electrode by Fatt and Katz constituted an
important step towards the “quantal hypothesis” [93], which was formulated by del Castillo and Katz
in 1954 [94]. It was clear now that synaptic transmission is mediated by the transmitter acetylcholine,
which is released very locally from the presynaptic motor nerve and interacts with receptors on the
postsynaptic membrane. With the advent of ultrastructure research and the observation of the numerous
synaptic vesicles in the presynaptic terminal [8,9], the “vesicle hypothesis” was brought forward. This
stated that “ACh may be contained in the vesicles and released in an all-or-none manner when the
vesicle collides with certain spots of the terminal membrane” [95]. By combining cell fractionation by
differential and density-gradient centrifugation with electron microscopy, Whittaker and colleagues
prepared so-called “synaptosome” preparations, which consisted of nerve endings containing most of
the particle-bound “vesicular” ACh [96]. The presence of ACh within synaptic vesicles from brain
was confirmed some ten years later by Whittaker and colleagues [97,98]. The enrichment of synaptic
vesicles in “active zones” was described in the frog NMJ by Couteaux and Pécot-Dechavassine [99]
and was beautifully depicted four years later using freeze-fracture preparations by Heuser, Reese, and
Landis [100]. From their electron microscopic studies using resting and stimulated muscles, Heuser
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and Reese also extracted compelling morphological evidence for the existence of synaptic vesicle
recycling [101], which proved to be perfectly correct [102]. In parallel to the groundbreaking work on the
molecular synaptic vesicle machinery (reviewed in [103]), Harlow and McMahan used ultrastructural
tomography of frog NMJs [104,105] to propose a mapping of morphologically identified active zone
material to molecular identities [106]. On the postsynaptic side, Takeuchi showed ACh-dependent
endplate currents involving sodium and potassium [107]. These were further carefully analyzed by
Katz and Miledi in 1970, leading to the first observations of elementary events of nAChRs opening
and closing upon ACh binding [108]. Iontophoretic mapping revealed an extremely high enrichment
of nAChR at the NMJ, since sensitivity to local application of ACh was high at the postsynaptic
surface but very low just next to it [109,110]. Significant technological advancements by Sakmann
and Neher led to the development of the patch-clamp method [111]. This permitted to study the
electrophysiological characteristics of nAChR in unprecedented detail and gave the first comprehensive
account of single-channel measurements [112]. With these studies, NMJ research had definitely reached
the molecular level, whose hallmarks are outlined in the next chapters.
6. Phase V: Nerve—Muscle Signaling—Feed Forward
While patch-clamp technology yielded precise information on the electrophysiological
characteristics in the 1970s, initial speculations about the existence of a cholinergic receptor on
muscle were drawn much earlier from pharmacological approaches. In 1905, Langley applied nicotine
to anaesthetized fowl with sciatic nerve sectioned on one side and observed tonic contracture of leg
muscles on both innervated and denervated legs unless antagonized by curare [113]. Notably, the same
was true for isolated gastrocnemius muscles, demonstrating the presence of a “receptive substance” on
the muscle that (i) can mediate muscle contraction, (ii) is activated by nicotine, and (iii) is inhibited
by curare. In 1914, Dale noted distinct “muscarinic” and “nicotinic” actions of acetylcholine, which
were chiefly found for target organs of the parasympathetic nervous system and on skeletal muscles,
respectively [114]. This suggested the existence of at least two cholinergic receptor classes with different
pharmacology, function, and localization. We know now that the first class, muscarinic receptors
(mAChR), make up a family of five different metabotropic G protein-coupled receptors (M1-M5),
which are either inhibited by scopolamine and/or atropine, and regulate heart rate, smooth muscle
contraction, glandular secretion as well as many fundamental central nervous functions [115]. At the
NMJ, muscarinic receptors are involved as presynaptic autoreceptors in the context of early postnatal
synaptic pruning were they cooperate with purinergic and Tropomyosin receptor kinase B receptors to
reinforce strong synaptic contacts and suppress weak ones in autocrine feedback loops [116,117]. The
second group, nicotinic acetylcholine receptors (nAChR) are pentameric ion channels and are grossly
grouped into neural/epithelial and muscle nicotinic receptors. In general, they are inhibited by curare
and are composed of five subunits.
The isolation, purification, and biochemical characterization of nAChR could be realized applying
newly developed methods of cell fractionation by differential centrifugation [118–120], electrophoresis
methods, the availability of electron microscopes, the synthesis of detergents such as Triton X-100,
and denaturing agents such as sodium dodecyl sulfate. Most important, though, was the help of
nature providing toxins that bind with high specificity to nAChR, such as the elapid snake venom
α-bungarotoxin, as an exquisite binding agent of nAChR [121–123]. In addition, the electroplax from
electric fish such as Electrophorus electricus and Torpedo species were recognized as an excellent source
of cholinergic synapse components [78,124]. The close relationship of electrocytes of the electric organ
to muscle had been described already in the 1890ies and the assumption that their signal transmission
was of cholinergic nature was confirmed in the 1940ies, for example by Feldberg and Fessard [125]. In
postsynaptic membranes of Torpedo electric organs, nAChR make up 40–50% of total protein, thus,
rendering this a convenient starting material for purifying synaptic constituents. Further fractionation
procedures yielded postsynaptic membrane fragment preparations (“microsacs”) that were highly
enriched in nAChR [126]. These could be solubilized and further purified e.g., by means of affinity
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chromatography with the receptor retaining its functional properties (inter alia [121]). The clarification
of the subunit composition of the isolated receptor complex, however, turned out to be difficult because
gel electrophoresis results appeared very variable due to preparation artefacts, uncontrolled proteolysis,
or other unknown differences. In 1974, the groups of Karlin [127] and Raftery [128] presented data that
indicated four subunits, in a putative ratio of 2:1:1:1. Finally, the protein sequences of all four nAChR
subunits were determined after another six years and these conclusively showed the nAChR as a
pentameric complex consisting of 2 × 40 kDa, 1 × 50 kDa, 1 × 60k Da, 1 × 65 kDa [114]. Based on these
findings, cloning of the corresponding cDNA sequences was enabled [129–133]. The hetero-pentameric,
α2βγδ composition of nAChR from Torpedo electroplax as well as mammalian muscle was further
supported by cryo-electron microscopy and later by crystallographic methods [134–136]. A novel,
mammalian-specific ε subunit was cloned in 1985 [133] and found to be characteristic of innervated
adult muscle [137,138] with strictly subsynaptic expression [139,140]. Many important components of
the NMJ, including rapsyn [141,142], agrin [143], MuSK [144], and LRP4 [145] were identified in the
following years. The rich field of research that has studied many of the interactions and downstream
effectors of these proteins as well as their involvement in NMJ development, maintenance, and aging
has been recently described in excellent reviews [146,147] and is therefore not further discussed here.
7. Phase VI: Postsynaptic Apparatus—nAChR Turnover
In parallel to the discovery of the nAChR and its binding partners, the field of molecular cell biology
became increasingly strong. Given the relatively easy access to NMJs, the development of radioactive,
fluorescent, peroxidase, or biotin-labeled α-bungarotoxin species [148–151] and the concomitant
advances in electron and fluorescence microscopy, the study of the postsynaptic apparatus at the
NMJ became a driving component in neuroscience research for the better understanding of molecular
machineries at synapses. As such, work on nAChR revealed major general features of neurotransmitter
receptors, including receptor clustering, receptor localization and regulation of receptor turnover.
With respect to the latter, muscle denervation was soon found to induce massive production of new
nAChR, which were largely located in extrajunctional regions (reviewed in [152]). Furthermore,
use of radiolabeled α-bungarotoxin showed that nAChR lifetime was strongly dependent on muscle
innervation status [123,153]. While the half-life of nAChR was several days in normal innervated muscle,
it went down to only approximately 24 h upon denervation. This finding was later reproduced by
several other studies using further, refined radiolabeling [154–162] or live-animal imaging methods with
fluorescently labeled α-bungarotoxin in wildtype [163] and in transgenic nAChRγ-GFP mice [164]. The
observations of nAChR endocytosis using electron microscopic analysis of electron-dense precipitates
mediated by peroxidase-coupled α-bungarotoxin [165,166] and of a nAChR recycling pool by a smart
α-bungarotoxin-biotin streptavidin-dye live imaging approach [167], paved the way for a series of
further studies on the pathways leading to nAChR recycling and degradation. These used live imaging
in combination with sequential application of differentially labeled α-bungarotoxins and often with
heterologous expression of genetically encoded molecular biosensors. As reviewed recently [168,169],
these studies identified a complex on nAChR recycling vesicles composed of rapsyn, myosin Va, and
protein kinase A [170–173]. Apparently, this complex got activated during the early postnatal period
in mouse [174]. This period is also characterized by a switch of nAChR subunit composition [175],
synapse elimination [176–178], and an increase in structural complexity [179,180], which is largely
mediated by podosome formation [181]. Furthermore, recycling of nAChR was found to be under
control of protein kinase C [173] and Ca2+/calmodulin-dependent kinase II [182]. Instead, autophagy
was reported to underlie the process of nAChR degradation [183,184]. This involved a complex of the
E3-ubiquitin ligase MuRF1, the autophagy adaptor p62, the autophagosome-formation factor Bif-1,
and the endosomal regulator Rab5 [52,53,185]. Notably, a recent work has shown that nAChR turnover
and MuRF1 expression are strongly altered upon sympathectomy [47], suggesting that these processes
are under strict sympathetic control. It has been debated, if the regulation of nAChR turnover by
sympathetic innervation could explain the clear beneficial effects of sympathicomimetic treatments
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of patients suffering from several forms of congenital myasthenic syndromes (CMS) [169,186,187],
a group of inherited neuromuscular disorders. However, it is early days to make final conclusions
here. In general, the fields of research on CMS and on the molecular machinery of the NMJ have
stimulated each other quite a lot. Based on the current knowledge, roughly 30 genes can be affected
in CMS and these were recently grouped into six major categories, i.e., (i) presynaptic, (ii) synaptic
space, (iii) postsynaptic, (iv) defects in NMJ development and maintenance, (v) defects in glycosylation,
and (vi) other syndromes [188]. Given that 18 of the genes involved in CMS were identified in the
short period between 2012 and 2018, it is to be expected that an increasingly precise understanding of
mechanisms at the neuromuscular apparatus in physiology and disease will follow from this synergy
in the coming years.
8. Phase VII: The Future of NMJ Research
It is difficult to predict the future directions of NMJ research, but owing to the apparent healthcare
needs in Western societies and/or recent scientific advancements, three fields appear to be rather
promising to these authors. However, as the fields of mouse genetics, optical tissue clearing, and
imaging have made such rapid progress in the past few decades, it appears to be a good time to
intensify studies of more systemic character. To begin with, the findings of NMJ fragmentation upon
aging [189], the reduction of aging-related fragmentation by caloric restriction [190], and advancements
in the understanding of the cellular [191] and molecular [184,192–194] mechanisms underlying this
fragmentation, there has been a growing interest to study the relationship between NMJ and sarcopenia.
This topic has been recently covered in several reviews [169,195–197]. Maybe still less explored, but
potentially relevant for the understanding of clinical features in certain motor neuron diseases, is the
concept of retrograde signaling from muscle to nerve. Indeed, different muscle-derived proteins were
found to be crucial for proper presynaptic development and NMJ positioning, at least in mouse. These
proteins could be grouped in transmembrane receptors (MuSK, LRP4, β1 integrin) [198–201], ECM
components (collagens IV and XIII, laminin β2) [202–205], and secretory signaling factors (FGF 7 and
10 and 22, Slit2) [202,206]. If similar mechanisms are critical in human beings, they might help to
explain why sporadic forms of the classical motor neuron disease, amyotrophic lateral sclerosis (ALS),
often show distal to proximal spreading of axonal conduction changes [207]. Whether muscle-driven
NMJ degeneration followed by retrograde aberrant signaling to the motor neuron can be involved in
such a scenario of “dying back” is still elusive. However, first studies using mice with conditional
muscle-specific expression of the ALS target gene, superoxide dismutase, showed fragmentation of
NMJs [208] and motor neuron loss [209]. Finally, it will be interesting to see what can be unraveled about
systemic interactions at the NMJ between the different types of innervation, as well as contributions
from terminal Schwann cells [178], kranocytes [210], muscle, blood vessels etc. The skeletal muscle
tissue has often been considered to be a simple system that is just good for robust responses to motor
nerve impulses. However, such a reductionist view does clearly not reflect the seamless adaptation of
this system to the multiple types of strain and fine control by the different participating components
that render skeletal muscle our mainstay through decades of life. We are looking forward to many new
discoveries on the motor endplate, the centennial model synapse and its embedding muscle tissue.
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